Reconstruction of a Genome-Scale Metabolic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Annotation-1 Annotation-1
Annotation-1 Baseline Resuscitation Normal Saline Resuscitation PFP Shock Annotation-1 Aminoacids Arginine and proline metabolism Carnitine and fatty acid metabolsim Glutamate metabolism Glycerophospholipid biosynthesis Glycolysis and sugars GSH homeostasis GSH homeostasis/Glyoxlate Hexosamine Indole and Tryptophan Nucleotides Other Panthothenate metabolism Pentose Phosphate Pathway Serine biosynthesis and one-carbon metabolism Signaling Sulfur metabolism TCA cycle urea cycle relative row min row max Baseline_14 Baseline_16 Baseline_13 Baseline_15 Baseline_22 Baseline_2 Baseline_12 Baseline_3 Baseline_4 Baseline_9 Baseline_7 Baseline_8 Shock_13 Shock_12 Shock_15 Shock_22 Shock_14 Shock_16 Shock_2 Shock_3 Shock_7 Shock_4 Shock_8 Shock_9 Res_NS_14 Res_NS_13 Res_NS_16 Res_NS_12 Res_NS_22 Res_NS_15 Res_PFP_2 Res_PFP_3 Res_PFP_7 Res_PFP_4 Res_PFP_8 Res_PFP_9 Annotation-1 Annotation-1 Annotation Annotation-1 L-Arginine Aminoacids L-Isoleucine Aminoacids Leucine Aminoacids L-Cysteine Aminoacids L-Alanine Aminoacids L-Aspartate Aminoacids L-Glutamate Aminoacids L-Glutamine Aminoacids L-Histidine Aminoacids L-Lysine Aminoacids L-Methionine Aminoacids L-Tyrosine Aminoacids L-Asparagine Aminoacids L-Threonine Aminoacids L-Cystine Aminoacids L-Serine Aminoacids L-Proline Aminoacids L-Valine Aminoacids L-Tryptophan Aminoacids Glycine Aminoacids L-Kynurenine Aminoacids L-Phenylalanine Aminoacids CMP Nucleotides 6-Hydroxynicotinate Nucleotides 5-6-Dihydrouracil Nucleotides AMP Nucleotides dAMP Nucleotides GMP Nucleotides Guanine Nucleotides 2-5-Dihydroxypyridine -
ATP-Citrate Lyase Has an Essential Role in Cytosolic Acetyl-Coa Production in Arabidopsis Beth Leann Fatland Iowa State University
Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2002 ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis Beth LeAnn Fatland Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Molecular Biology Commons, and the Plant Sciences Commons Recommended Citation Fatland, Beth LeAnn, "ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis " (2002). Retrospective Theses and Dissertations. 1218. https://lib.dr.iastate.edu/rtd/1218 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis by Beth LeAnn Fatland A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Plant Physiology Program of Study Committee: Eve Syrkin Wurtele (Major Professor) James Colbert Harry Homer Basil Nikolau Martin Spalding Iowa State University Ames, Iowa 2002 UMI Number: 3158393 INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleed-through, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. -
Next-Generation Sequencing of Representational Difference Analysis
Planta DOI 10.1007/s00425-017-2657-0 ORIGINAL ARTICLE Next-generation sequencing of representational difference analysis products for identification of genes involved in diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum) 1 1 1 1 Joanna Ciura • Magdalena Szeliga • Michalina Grzesik • Mirosław Tyrka Received: 19 August 2016 / Accepted: 30 January 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com Abstract Within the transcripts related to sterol and steroidal Main conclusion Representational difference analysis saponin biosynthesis, we discovered novel candidate of cDNA was performed and differential products were genes of diosgenin biosynthesis and validated their sequenced and annotated. Candidate genes involved in expression using quantitative RT-PCR analysis. Based on biosynthesis of diosgenin in fenugreek were identified. these findings, we supported the idea that diosgenin is Detailed mechanism of diosgenin synthesis was biosynthesized from cycloartenol via cholesterol. This is proposed. the first report on the next-generation sequencing of cDNA-RDA products. Analysis of the transcriptomes Fenugreek (Trigonella foenum-graecum L.) is a valuable enriched in low copy sequences contributed substantially medicinal and crop plant. It belongs to Fabaceae family to our understanding of the biochemical pathways of and has a unique potential to synthesize valuable steroidal steroid synthesis in fenugreek. saponins, e.g., diosgenin. Elicitation (methyl jasmonate) and precursor feeding (cholesterol and squalene) were Keywords Diosgenin Á Next-generation sequencing Á used to enhance the content of sterols and steroidal Phytosterols Á Representational difference analysis of sapogenins in in vitro grown plants for representational cDNA Á Steroidal saponins Á Transcriptome user-friendly difference analysis of cDNA (cDNA-RDA). -
35 Disorders of Purine and Pyrimidine Metabolism
35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP). -
(12) United States Patent (10) Patent No.: US 6,441,206 B1 Mikkonen Et Al
USOO64.41206B1 (12) United States Patent (10) Patent No.: US 6,441,206 B1 Mikkonen et al. (45) Date of Patent: Aug. 27, 2002 (54) USE OF ORGANIC ACID ESTERS IN GB 1298047 11/1972 DIETARY FAT GB 2288805 * 7/1995 JP 588.098 A 1/1983 (75) Inventors: Hannu Mikkonen, Rajamäki; Elina JP 9194345 A 7/1997 Heikkilä, Vantaa, Erkki Anttila, Algy o Rajamäki; Anneli Lindeman, Espoo, all WO A19806405 2/1998 of (FI) OTHER PUBLICATIONS (73) Assignee: Raisio Benecol Ltd., Raisio (FI) Miettinen et al., New Technologies for Healthy Foods, pp. * Y NotOtice: Subjubject to anyy disclaimer,disclai theh term off thisthi 71-83 (1997). patent is extended or adjusted under 35 Habib et al., Sci. Pharm. vol. 49, pp. 253–257 (1981). U.S.C. 154(b) by 0 days. Mukhina e al., STN International, vol. 88, No. 7, pp. 1429-1430 (1977). (21) Appl. No.: 09/508,295 Mukhina et al., STN International, vol. 67, No. 9, pp. 587-589 (1967). (22) PCT Filed: Sep. 9, 1998 Tuomisto et al., Farmakologia Ja Toksikologia, pp. 526-534 (86) PCT No.: PCT/FI98/00707 (1982). Ikeda et al., J. Nutr Sci. Vitaminol, vol. 35, pp. 361-369 S371 (c)(1), (1989). (2), (4) Date: May 12, 2000 Heinemann et al., Eur: J. Clin. Pharmacol., 40(Suppl 1), pp. S59–S63 (1991). (87) PCT Pub. No.: WO99/15546 Mattson et al., J. Nutr, vol. 107, pp. 1139-1146 (1977). PCT Pub. Date: Apr. 1, 1999 Herting et al., Fed. Proc., vol. 19, pp. 18, (1960). Takagi et al., J. -
(12) United States Patent (10) Patent No.: US 9,725,399 B2 Petrie Et Al
USO09725399B2 (12) United States Patent (10) Patent No.: US 9,725,399 B2 Petrie et al. (45) Date of Patent: Aug. 8, 2017 (54) LPID COMPRISING LONG CHAN (51) Int. Cl. POLYUNSATURATED FATTY ACDS C07C 69/587 (2006.01) CIIB I/O (2006.01) (71) Applicants: Commonwealth Scientific and (Continued) Industrial Research Organisation, (52) U.S. Cl. Acton, Australian Capital Territory CPC .............. C07C 69/587 (2013.01); A23D 9/00 (AU): Nuseed Pty Ltd, Laverton North, (2013.01); A61K 36/31 (2013.01): CIIB I/10 Victoria (AU); Grains Research and (2013.01); A61 K 2.236/00 (2013.01) Development Corporation, Barton, (58) Field of Classification Search Australian Capital Territory (AU) CPC .......................... C12N 15/8247; CO7C 69/587 See application file for complete search history. (72) Inventors: James Robertson Petrie, Goulburn (AU); Surinder Pal Singh, Downer (56) References Cited (AU); Pushkar Shrestha, Lawson U.S. PATENT DOCUMENTS (AU); Jason Timothy McAllister, Portarlington (AU); Robert Charles De 4,399.216 A 8, 1983 Axel et al. Feyter, Monash (AU); Malcolm David 5,004,863. A 4, 1991 Umbeck Devine, Vernon (CA) (Continued) (73) Assignees: COMMONWEALTH SCIENTIFIC FOREIGN PATENT DOCUMENTS AND INDUSTRIAL RESEARCH AU 667939 1, 1994 ORGANISATION, Campbell (AU): AU 200059710 B2 12/2000 NUSEED PTY LTD, Laverton North (Continued) (AU); GRAINS RESEARCH AND DEVELOPMENT CORPORATION, Barton (AU) OTHER PUBLICATIONS Ruiz-Lopez, N. et al., “Metabolic engineering of the omega-3 long (*) Notice: Subject to any disclaimer, the term of this chain polyunsaturated fatty acid biosynthetic pathway into trans patent is extended or adjusted under 35 genic plants' Journal of Experimental botany, 2012, vol. -
Clinical Symptoms of Defects in Pyrimidine Metabolism
ClinicalClinical symptomssymptoms ofof DefectsDefects inin pyrimidinepyrimidine metabolismmetabolism Birgit Assmann Department of General Pediatrics Universtiy Children‘s Hospital Düsseldorf, Germany Overview • Biosynthesis: UMP Synthase • Degradation: –– PyrimidinePyrimidine 55‘‘--Nucleotidase(UMPNucleotidase(UMP--Hydrolase)Hydrolase) – [Thymidine-Phosphorylase, mitochondrial] –– DihydropyrimidineDihydropyrimidine DehydrogenaseDehydrogenase –– DihydropyrimidinaseDihydropyrimidinase –– UreidopropionaseUreidopropionase HCO3+gluNH2 carbamoyl-P orotic acid OMP OPRT UMP OD UMPS UMPSUMPS == uridinemonophosphateuridinemonophosphate synthasesynthase Bifunctional enzyme (one gene): a) Orotate phosphoribosyl transferase (OPRT) b) Orotidine decarboxylase (OD) UMPS deficiency • = Hereditary orotic aciduria Hallmarks:Hallmarks: - MegaloblasticMegaloblastic anemiaanemia inin infantsinfants >> IfIf untreateduntreated:: FailureFailure toto thrivethrive PsychomotorPsychomotor retardationretardation • Therapy: uridine (≥100-150 mg/kg/d) Defects of pyrimidine degradation • Pyrimidine 5‘-Nucleotidase deficiency - chronic hemolytic anemia + basophilic stippling of erythrocytes • Thymidine phosphorylase deficiency = MNGIE=Mitoch. NeuroGastroIntestinal Encephalomyopathy Mitochondrial disorder with elevatedelevated urinaryurinary thymidinethymidine excretionexcretion HCO3+gluNH2 carbamoyl-P orotic acid OMP TMP UMP UMPS thymidine cytosolic 5‘- uridine Thym. Nucleotidase phosphor ylase thymine uracil Pyrimidine 5‘-Nucleotidase- SuperactivitySuperactivity • Existence -
The Xanthines (Theobromine and Aminophyllin)
effect of this might conceivably escape detection in THE XANTHINES (THEOBROMINE AND individuals engaged in very heavy work. From this AMINOPHYLLINE) IN THE TREAT- point of view our subjects were particularly favorable for this since of as MENT OF CARDIAC PAIN study, most them, shown in the table, were not engaged in any occupation. HARRY M.D. GOLD, GLYCERYL TRINITRATE TEST NATHANIEL T. M.D. KWIT, Early in the course of the study it was believed AND desirable to HAROLD M.D. restrict the selection of patients to those OTTO, who could establish their qualifications for service in NEW YORK such a study as this by their ability to distinguish An endeavor was made in this study to secure evi- between the efficacy of glyceryl trinitrate taken under dence on the question of whether the xanthines relieve the tongue and a soluble placebo tablet taken in the cardiac pain. same manner for relief during attacks of pain. The SELECTION OF PATIENTS discovery of several patients who found the two equally effective those who had suffered an of The were 100 ambulant in attend- among attack subjects patients thrombosis and were to thoracic ance at the cardiac in whom the of coronary subject pain clinic, diagnosis on effort led us to abandon this restriction. arteriosclerotic heart disease with cardiac pain was made, in accordance with the nomenclature and criteria The results obtained in sixty patients in whom the the New York Heart Association.1 glyceryl trinitrate test was made are of some interest. adopted by These received trinitrate were selected from a total case load of patients glyceryl tablets, %0o They approxi- or cr 0.4 which were mately 700 patients, representing an average sample /4so grain (0.6 mg.), they of the cardiac clinic several racial directed to take under the tongue at the onset of an population, comprising attack of In of these of groups, both native and born. -
Chocolate, Theobromine, Dogs, and Other Great Stuff
Nancy Lowry, Professor of Chemistry, Hampshire College, Amherst, MA [email protected] Chocolate, Theobromine, Dogs, and Other Great Stuff. Chocolate is now considered a health food, according to many news reports. It provides a goodly dose of antioxidants, prolongs the lives of Dutch men, contains compounds that chemically echo tetrahydocannabinoid and encourage feelings of love, and it even “may halve the risk of dying,” according to a recent headline in the New Scientist. On the other hand, if chocolate is included in the diet in therapeutic doses, it will also most assuredly lead to obesity. Furthermore, the amounts of anandamide (the THC mimic) and phenylethylamine (the so-called “love” compound) are present in chocolate in very, very low amounts. And finally, we all have a 100% chance of dying at some time, so a headline that talks about cutting our chance of dying in half makes no sense. Nevertheless, chocolate is great stuff. It comes in many varieties. One end of the spectrum is bitter baking chocolate; adding sugar provides chocolate of various degrees of sweetness. Adding milk finally brings us to milk chocolate, which many people consider barely makes it over the line into chocolate. White chocolate is only cocoa butter fat, and really isn’t chocolate at all. Over 600 different molecules contribute to the taste of chocolate. Many people talk about the caffeine in chocolate, but there is relatively very little caffeine in chocolate; the compound that particularly characterizes chocolate is theobromine, a very close relative of caffeine. There is six to ten times more theobromine in chocolate than caffeine. -
In Vitro Stiumlation of Ergosterol from Coelastrella Terrestris by Using Squalene and Studying Antioxidant Effect
Sys Rev Pharm 2020;11(11):1795-1803 A multifaceted review journal in the field of pharmacy In Vitro Stiumlation of Ergosterol from Coelastrella Terrestris by Using Squalene and Studying Antioxidant Effect Altaf AL-Rawi, Fikrat M. Hassan* and Bushra M.J.Alwash Department of Biology, College of Science for Women, University of Baghdad, Baghdad – Iraq *Corresponding author: [email protected] ABSTRACT Ergosterol is one of the most important chemicals produced by algae, specifically Keywords: Algae, Chlorophyceae, Coelastrella, Squalene, Secondary products, by microalgae, and the Squalene is the commonly known as a precursor for Antioxidant. biosynthesis of ergosterol. Coelastrella terrestris was isolated from sediment sample collected from the banks of Tigris River and the modified Chu 10 culture Correspondence: medium was used for algal growth and determining the optimum growth Fikrat M. Hassan condition (25) °C and 268 µE. mˉ². secˉ¹). In an attempt to further maximize Department of Biology, College of Science for Women, University of Baghdad, ergosterol production by C. terrestris. The optimal temperature and light growth Baghdad10070 – Iraq. conditions 30 ºC and 300 µE. mˉ².secˉ¹ were tested under of different Squalene Email: [email protected] concentrations treatments (0.1, 0.25, 0.5 and 1٪). This combined treatment of optimal culture conditions and Squalene was caused an extremely a highest ergosterol production recorded (533.3 ± 15.92 ppm) at 1% squalene in phase 2, while the lowest production (54.3 ± 2.48ppm) was at 0.10% Squalene in phase3. The present study has further investigated the potential antioxidant activity of C. terrestis crude extract and ergosteoleby the ability to scavenging free radical 2.2 diphenyl-1-picrylhydrzyl (DPPH). -
1 AMINO ACIDS Commonly, 21 L-Amino Acids Encoded by DNA Represent the Building Blocks of Animal, Plant, and Microbial Proteins
1 AMINO ACIDS Commonly, 21 L-amino acids encoded by DNA represent the building blocks of animal, plant, and microbial proteins. The basic amino acids encountered in proteins are called proteinogenic amino acids 1.1). Biosynthesis of some of these amino acids proceeds by ribosomal processes only in microorganisms and plants and the ability to synthesize them is lacking in animals, including human beings. These amino acids have to be obtained in the diet (or produced by hydrolysis of body proteins) since they are required for normal good health and are referred to as essential amino acids. The essential amino acids are arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. The rest of encoded amino acids are referred to as non-essential amino acids (alanine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and tyrosine). Arginine and histidine are classified as essential, sometimes as semi-essential amino acids, as their amount synthesized in the body is not sufficient for normal growth of children. Although it is itself non-essential, cysteine (classified as conditionally essential amino acid) can partly replace methionine, which is an essential amino acid. Similarly, tyrosine can partly replace phenylalanine. 1.1 The glutamic acid group 1.1.1 Glutamic acid and glutamine Free ammonium ions are toxic to living cells and are rapidly incorporated into organic compounds. One of such transformations is the reaction of ammonia with 2-oxoglutaric acid from the citric acid cycle to produce L-glutamic acid. This reaction is known as reductive amination. Glutamic acid is accordingly the amino acid generated first as both constituent of proteins and a biosynthetic precursor. -
Sample Thesis Title with a Concise And
DESIGN, SYNTHESIS AND STUDIES OF GUANIDINIUM-BASED INHIBITORS FOR ISOPRENOID BIOSYNTHETIC PATHWAY ENZYMES by Walid Abdelmagid MChem., The University of Liverpool, 2011 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Doctor of Philosophy in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Chemistry) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) October 2019 © Walid Abdelmagid, 2019 i The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: DESIGN, SYNTHESIS AND STUDIES OF GUANIDINIUM-BASED INHIBITORS FOR ISOPRENOID BIOSYNTHETIC PATHWAY ENZYMES submitted by Walid Abdelmagid in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry Examining Committee: Martin Tanner Supervisor Stephen Withers Supervisory Committee Member Glenn Sammis Supervisory Committee Member Kathryn Ryan University Examiner David Chen University Examiner Additional Supervisory Committee Members: Supervisory Committee Member Supervisory Committee Member ii Abstract In this thesis an inhibition strategy was developed to target enzymes that utilize allylic diphosphates. Positively-charged inhibitors that mimic the transition states/intermediates formed with these enzymes were synthesized. In chapter two, inhibitor 2 containing a guanidinium moiety appended to a phosphonylphosphinate was designed to mimic the transition state for the dissociation of dimethylallyl diphosphate into an allylic carbocation-pyrophosphate ion-pair. To test for the effectiveness of incorporating a guanidinium functionality into inhibitors of human farnesyl diphosphate synthase, inhibitors 3 and 4 were also prepared. Inhibitor 3 has a positive charge localized onto one atom, and inhibitor 4 is isosteric to inhibitor 2, but lacks positive charge. The inhibitors displayed IC50 values that were significantly higher than the substrate Km value, indicating that the positive charge did not result in tight binding to the enzyme.